Quanterix Corp (NAS:QTRX)
$ 12.47 0.41 (3.4%) Market Cap: 478.59 Mil Enterprise Value: 221.31 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 70/100

Quanterix Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2022 / 01:15PM GMT
Release Date Price: $33.09 (-0.42%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. Welcome to Day 4 of the health care conference. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this morning, Quanterix.

Before I turn it over to Kevin, just a quick reminder. You can submit questions through the website.

And with that, let me turn it over to Kevin.

E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO

Thanks very much, Tycho. I think this is the 20th time I've presented at JPMorgan, and I would encourage investors to look at the regulatory filings. We will be making some forward-looking statements.

Now to start off in this conference, it's been incredible the number of meetings we've had over the last 4 days. And we've tried to incorporate some of the top questions that we were seeing from our investor base into this agenda.

But starting off with our achievements in 2021. We have this symbiotic relationship between RUO research and diagnostics that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot